Have a personal or library account? Click to login
Serum Atrial Natriuretic Peptide, NPPA Promoter Methylation, and Cardiovascular Disease: A 10-year Follow-Up Study in Chinese Adults Cover

Serum Atrial Natriuretic Peptide, NPPA Promoter Methylation, and Cardiovascular Disease: A 10-year Follow-Up Study in Chinese Adults

Global Heart
Volume 17 (2022): Issue 1
By: Linan Chen,  Jing Li,  Min Zhang,  Qiu Zhang,  Lei Wu,  Ying Lu,  Yan He,  Jun Jiang,  Xiaolong Zhang,  Jianwei Hu,  Yi Ding,  Mingzhi Zhang and  Hao Peng  
Open Access
|Apr 2022

References

  1. 1Rubattu S, Stanzione R, Di Angelantonio E, et al. Atrial natriuretic peptide gene polymorphisms and risk of ischemic stroke in humans. Stroke. 2004; 35(4): 8148. DOI: 10.1161/01.STR.0000119381.52589.AB
    Back to article
  2. 2Xing DG, Zhang DY, Wang ZF, Ding DL, Wang J, Wang YJ. Correlations of ANP genetic polymorphisms and serum levels with ischemic stroke risk: A meta-analysis. Genetic testing and molecular biomarkers. 2014; 18(5): 349–56. DOI: 10.1089/gtmb.2013.0498
    Back to article
  3. 3John SW, Krege JH, Oliver PM, et al. Genetic decreases in atrial natriuretic peptide and salt-sensitive hypertension. Science (New York, NY). 1995; 267(5198): 679–81. DOI: 10.1126/science.7839143
    Back to article
  4. 4Conen D, Glynn RJ, Buring JE, Ridker PM, Zee RY. Natriuretic peptide precursor a gene polymorphisms and risk of blood pressure progression and incident hypertension. Hypertension (Dallas, Tex: 1979). 2007; 50(6): 1114–9. DOI: 10.1161/HYPERTENSIONAHA.107.097634
    Back to article
  5. 5Casco VH, Veinot JP, Kuroski de Bold ML, Masters RG, Stevenson MM, de Bold AJ. Natriuretic peptide system gene expression in human coronary arteries. The journal of histochemistry and cytochemistry: Official journal of the Histochemistry Society. 2002; 50(6): 799–809. DOI: 10.1177/002215540205000606
    Back to article
  6. 6Zois NE, Bartels ED, Hunter I, Kousholt BS, Olsen LH, Goetze JP. Natriuretic peptides in cardiometabolic regulation and disease. Nature reviews Cardiology. 2014; 11(7): 403–12. DOI: 10.1038/nrcardio.2014.64
    Back to article
  7. 7Volpe M, Rubattu S, Burnett J, Jr. Natriuretic peptides in cardiovascular diseases: Current use and perspectives. European Heart Journal. 2014; 35(7): 419–25. DOI: 10.1093/eurheartj/eht466
    Back to article
  8. 8Berntsson J, Zia E, Borné Y, Melander O, Hedblad B, Engström G. Plasma natriuretic peptides and incidence of subtypes of ischemic stroke. Cerebrovascular Diseases (Basel, Switzerland). 2014; 37(6): 444–50. DOI: 10.1159/000363279
    Back to article
  9. 9Berntsson J, Smith JG, Nilsson PM, Hedblad B, Melander O, Engström G. Pro-atrial natriuretic peptide and prediction of atrial fibrillation and stroke: The Malmö Preventive Project. European Journal of Preventive Cardiology. 2017; 24(8): 788–95. DOI: 10.1177/2047487317693948
    Back to article
  10. 10Kitakaze M, Asakura M, Kim J, et al. Human atrial natriuretic peptide and nicorandil as adjuncts to reperfusion treatment for acute myocardial infarction (J-WIND): two randomised trials. Lancet (London, England). 2007; 370(9597): 1483–93. DOI: 10.1016/S0140-6736(07)61634-1
    Back to article
  11. 11Lyu T, Zhao Y, Zhang T, et al. Natriuretic peptides as an adjunctive treatment for acute myocardial infarction: Insights from the meta-analysis of 1,389 patients from 20 trials. International Heart Journal. 2014; 55(1): 8–16. DOI: 10.1536/ihj.13-109
    Back to article
  12. 12Ogiso M, Isogai T, Okabe Y, Ito K, Tsuji M, Tanaka H. Effect of carperitide on in-hospital mortality of patients admitted for heart failure: Propensity score analyses. Heart and vessels. 2017; 32(8): 916–25. DOI: 10.1007/s00380-017-0952-0
    Back to article
  13. 13Nomura F, Kurobe N, Mori Y, et al. Multicenter prospective investigation on efficacy and safety of carperitide as a first-line drug for acute heart failure syndrome with preserved blood pressure: COMPASS: Carperitide Effects Observed Through Monitoring Dyspnea in Acute Decompensated Heart Failure Study. Circulation journal: Official journal of the Japanese Circulation Society. 2008; 72(11): 1777–86. DOI: 10.1253/circj.CJ-07-0760
    Back to article
  14. 14Suwa M, Seino Y, Nomachi Y, Matsuki S, Funahashi K. Multicenter prospective investigation on efficacy and safety of carperitide for acute heart failure in the ‘real world’ of therapy. Circulation Journal: Official Journal of the Japanese Circulation Society. 2005; 69(3): 283–90. DOI: 10.1253/circj.69.283
    Back to article
  15. 15Hattori H, Minami Y, Mizuno M, et al. Differences in hemodynamic responses between intravenous carperitide and nicorandil in patients with acute heart failure syndromes. Heart and Vessels. 2013; 28(3): 345–51. DOI: 10.1007/s00380-012-0252-7
    Back to article
  16. 16Mizuno A, Iguchi H, Sawada Y, et al. The impact of carperitide usage on the cost of hospitalization and outcome in patients with acute heart failure: High value care vs. low value care campaign in Japan. International Journal of Cardiology. 2017; 241: 243–8. DOI: 10.1016/j.ijcard.2017.04.078
    Back to article
  17. 17Kobayashi D, Yamaguchi N, Takahashi O, Deshpande GA, Fukui T. Human atrial natriuretic peptide treatment for acute heart failure: A systematic review of efficacy and mortality. The Canadian Journal of Cardiology. 2012; 28(1): 102–9. DOI: 10.1016/j.cjca.2011.04.011
    Back to article
  18. 18Nagai T, Iwakami N, Nakai M, et al. Effect of intravenous carperitide versus nitrates as first-line vasodilators on in-hospital outcomes in hospitalized patients with acute heart failure: Insight from a nationwide claim-based database. International Journal of Cardiology. 2019; 280: 104–9. DOI: 10.1016/j.ijcard.2019.01.049
    Back to article
  19. 19Rubattu S, Sciarretta S, Volpe M. Atrial natriuretic peptide gene variants and circulating levels: implications in cardiovascular diseases. Clinical Science (London, England: 1979). 2014; 127(1): 1–13. DOI: 10.1042/CS20130427
    Back to article
  20. 20Cannone V, Huntley BK, Olson TM, et al. Atrial natriuretic peptide genetic variant rs5065 and risk for cardiovascular disease in the general community: a 9-year follow-up study. Hypertension (Dallas, Tex: 1979). 2013; 62(5): 860–5. DOI: 10.1161/HYPERTENSIONAHA.113.01344
    Back to article
  21. 21Rubattu S, Ridker P, Stampfer MJ, Volpe M, Hennekens CH, Lindpaintner K. The gene encoding atrial natriuretic peptide and the risk of human stroke. Circulation. 1999; 100(16): 1722–6. DOI: 10.1161/01.CIR.100.16.1722
    Back to article
  22. 22Kim JH, Jang BH, Go HY, et al. Potential association between frequent nonsynonymous variant of NPPA and cardioembolic stroke. DNA and cell biology. 2012; 31(6): 993–1000. DOI: 10.1089/dna.2011.1463
    Back to article
  23. 23Barbato E, Bartunek J, Mangiacapra F, et al. Influence of rs5065 atrial natriuretic peptide gene variant on coronary artery disease. Journal of the American College of Cardiology. 2012; 59(20): 1763–70. DOI: 10.1016/j.jacc.2012.02.017
    Back to article
  24. 24Liu YH, Zhou YW, Yang JA, et al. Gene polymorphisms associated with susceptibility to coronary artery disease in Han Chinese people. Genetics and molecular research: GMR. 2014; 13(2): 2619–27. DOI: 10.4238/2014.April.8.4
    Back to article
  25. 25Zhu H, Wu LF, Mo XB, et al. Rheumatoid arthritis-associated DNA methylation sites in peripheral blood mononuclear cells. Annals of the Rheumatic Diseases. 2019; 78(1): 36–42. DOI: 10.1136/annrheumdis-2018-213970
    Back to article
  26. 26Soriano-Tárraga C, Lazcano U, Giralt-Steinhauer E, et al. Identification of 20 novel loci associated with ischaemic stroke. Epigenome-wide association study. Epigenetics. 2020; 15(9): 988–97. DOI: 10.1080/15592294.2020.1746507
    Back to article
  27. 27Nakatochi M, Ichihara S, Yamamoto K, et al. Epigenome-wide association of myocardial infarction with DNA methylation sites at loci related to cardiovascular disease. Clinical Epigenetics. 2017; 9: 54. DOI: 10.1186/s13148-017-0353-3
    Back to article
  28. 28Rask-Andersen M, Martinsson D, Ahsan M, et al. Epigenome-wide association study reveals differential DNA methylation in individuals with a history of myocardial infarction. Human molecular genetics. 2016; 25(21): 4739–48. DOI: 10.1093/hmg/ddw302
    Back to article
  29. 29Peng H, Zhang Q, Cai X, et al. Association Between High Serum Soluble Corin and Hypertension: A Cross-Sectional Study in a General Population of China. American journal of Hypertension. 2015; 28(9): 1141–9. DOI: 10.1093/ajh/hpv002
    Back to article
  30. 30Mair J, Lindahl B, Giannitsis E, et al. Will sacubitril-valsartan diminish the clinical utility of B-type natriuretic peptide testing in acute cardiac care? European Heart Journal Acute Cardiovascular Care. 2017; 6(4): 321–8. DOI: 10.1177/2048872615626355
    Back to article
  31. 31Li J, Zhu J, Ren L, et al. Association between NPPA promoter methylation and hypertension: results from Gusu cohort and replication in an independent sample. Clinical Epigenetics. 2020; 12(1): 133. DOI: 10.1186/s13148-020-00927-0
    Back to article
  32. 32Pickering TG, Hall JE, Appel LJ, et al. Recommendations for blood pressure measurement in humans: An AHA scientific statement from the Council on High Blood Pressure Research Professional and Public Education Subcommittee. Journal of Clinical Hypertension (Greenwich, Conn). 2005; 7(2): 102–9. DOI: 10.1111/j.1524-6175.2005.04377.x
    Back to article
  33. 33Staffa SJ, Zurakowski D. Competing risks analysis of time-to-event data for cardiovascular surgeons. J Thorac Cardiovasc Surg. 2020; 159(6). DOI: 10.1016/j.jtcvs.2019.10.153
    Back to article
  34. 34Zaykin DV, Zhivotovsky LA, Westfall PH, Weir BS. Truncated product method for combining P-values. Genetic Epidemiology. 2002; 22(2): 170–85. DOI: 10.1002/gepi.0042
    Back to article
  35. 35Sheng X, Yang J. Truncated Product Methods for Panel Unit Root Tests. Oxford bulletin of economics and statistics. 2013; 75(4): 624–36. DOI: 10.1111/j.1468-0084.2012.00705.x
    Back to article
  36. 36Peng H, Zhu Y, Strachan E, et al. Childhood Trauma, DNA Methylation of Stress-Related Genes, and Depression: Findings From Two Monozygotic Twin Studies. Psychosomatic Medicine. 2018; 80(7): 599–608. DOI: 10.1097/PSY.0000000000000604
    Back to article
  37. 37Komaki S, Shiwa Y, Furukawa R, et al. iMETHYL: An integrative database of human DNA methylation, gene expression, and genomic variation. Human Genome Variation. 2018; 5: 18008. DOI: 10.1038/hgv.2018.8
    Back to article
  38. 38Zhang L, Cheng L, He M, Hu B, Wu T. ANP T2238C, C-664G gene polymorphism and coronary heart disease in Chinese population. Journal of Huazhong University of Science and Technology Medical sciences = Hua zhong ke ji da xue xue bao Yi xue Ying De wen ban = Huazhong keji daxue xuebao Yixue Yingdewen ban. 2006; 26(5): 528–30. DOI: 10.1007/s11596-006-0510-y
    Back to article
  39. 39Gruchala M, Ciećwierz D, Wasag B, et al. Association of the ScaI atrial natriuretic peptide gene polymorphism with nonfatal myocardial infarction and extent of coronary artery disease. American Heart Journal. 2003; 145(1): 125–31. DOI: 10.1067/mhj.2003.52
    Back to article
  40. 40Meder B, Haas J, Sedaghat-Hamedani F, et al. Epigenome-Wide Association Study Identifies Cardiac Gene Patterning and a Novel Class of Biomarkers for Heart Failure. Circulation. 2017; 136(16): 1528–44. DOI: 10.1161/CIRCULATIONAHA.117.027355
    Back to article
  41. 41Lund G, Andersson L, Lauria M, et al. DNA methylation polymorphisms precede any histological sign of atherosclerosis in mice lacking apolipoprotein E. The Journal of Biological Chemistry. 2004; 279(28): 29147–54. DOI: 10.1074/jbc.M403618200
    Back to article
  42. 42Baccarelli A, Wright R, Bollati V, et al. Ischemic heart disease and stroke in relation to blood DNA methylation. Epidemiology (Cambridge, Mass). 2010; 21(6): 819–28. DOI: 10.1097/EDE.0b013e3181f20457
    Back to article
  43. 43Menke A, Binder EB. Epigenetic alterations in depression and antidepressant treatment. Dialogues in Clinical Neuroscience. 2014; 16(3): 395–404. DOI: 10.31887/DCNS.2014.16.3/amenke
    Back to article
  44. 44Uddin M, Koenen KC, Aiello AE, Wildman DE, de los Santos R, Galea S. Epigenetic and inflammatory marker profiles associated with depression in a community-based epidemiologic sample. Psychological Medicine. 2011; 41(5): 997–1007. DOI: 10.1017/S0033291710001674
    Back to article
  45. 45Pu W, Wang C, Chen S, et al. Targeted bisulfite sequencing identified a panel of DNA methylation-based biomarkers for esophageal squamous cell carcinoma (ESCC). Clinical epigenetics. 2017; 9: 129. DOI: 10.1186/s13148-017-0430-7
    Back to article
DOI: https://doi.org/10.5334/gh.1116 | Journal eISSN: 2211-8179
Journal RSS Feed
Language: English
Submitted on: Dec 29, 2021
Accepted on: Mar 16, 2022
Published on: Apr 7, 2022
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
Keywords:
atrial natriuretic peptide,
cardiovascular disease,
prospective cohort study,
DNA methylation

© 2022 Linan Chen, Jing Li, Min Zhang, Qiu Zhang, Lei Wu, Ying Lu, Yan He, Jun Jiang, Xiaolong Zhang, Jianwei Hu, Yi Ding, Mingzhi Zhang, Hao Peng, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.

Previous articleVolume 17 (2022): Issue 1Next article